Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 3/20 | 0.59 |
| ▸ | REN | P00797 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA5A | P35218 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 2/20 | 0.47 |
| ▸ | CTSS | P25774 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7278824 | 0.90 | CTSD (0.59) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL7270655 | 0.88 | CTSD (0.62) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL6132144 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL6449641 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL6445103 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL6446151 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL9232828 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL6446780 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL9740721 | 0.83 | CTSD (0.76) | CTSDRENCA2CA5ACASP3 | |
| SCHEMBL7270660 | 0.82 | CTSD (0.60) | CTSDRENCA2CA5ACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |